Sinopharm Group Co Ltd (1099) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Sinopharm Group Co Ltd (Sinopharm), a subsidiary of China National Pharmaceutical Group Corp is a distributor of pharmaceutical and healthcare products. The group provides distribution, logistics and other value-added services to foreign and domestic manufacturers and suppliers of pharmaceuticals, medical products and supplies and other healthcare products. It also serves hospitals, retail drug stores and primary health services institutions. Sinopharm also manufactures and sells pharmaceuticals, chemical reagents and laboratory supplies, and engages in the innovation of pharmaceutical, medical services and other health-related industries. Besides, the group manages a chain of medicine stores across China through direct operations and franchises to market pharmaceutical and healthcare products. Sinopharm is headquartered in Shanghai, China.

Sinopharm Group Co Ltd (1099) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 5
List of Figures 5
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sinopharm Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Sinopharm Plans to Acquire Pharmacy Business from Shanghai Fosun Pharma 13
Partnerships 14
Chi-Med Forms Joint Venture with Sinopharm 14
Mitsubishi Forms Joint Venture With Sinopharm 15
China NT Pharma To Form Joint Venture With Sinopharm 16
Licensing Agreements 17
Aeterna Zentaris Enters into Licensing Agreement with Sinopharm A-Think for Zoptarelin Doxorubicin 17
Provectus to Enter into Licensing Agreement with Sinopharm-CSIPI and Sinopharm A-THINK for PV-10 18
Equity Offering 20
Sinopharm Raised USD728 Million in Private Placement of Shares 20
Sinopharm Completes Private Placement Of Shares For US$525 Million 22
Debt Offering 24
Sinopharm Group Plans Public Offering Of Bonds For US$633 Million 24
Acquisition 25
China National Accord Medicines Plans to Acquire Remaining 90% Stake in Zhuhai-Based Pharma Firm for USD1.43 Million 25
Shanghai Shyndec Pharma to Acquire Stakes in 12 Pharma Companies for USD1.2 Billion 26
Sinopharm Plans to Acquire Three Pharmacies from Shanghai Fosun Pharma for USD67 Million 27
Hutchison China MediTech And Sinopharm Acquires 51% Stake In Sinopharm Holding HuYong Pharma For USD9.6 Million 28
Mitsubishi And Medipal Each Acquire 20% Stake In Sinopharm Holding Beijing Tianxingpuxin Bio-Med 30
Sinopharm Group To Acquire 80% Stake In Sinopharm Group Shanxi For US$132.6 Million 31
Merro Pharma To Sell 42.5% Stake In Shanghai Merro Pharma To Sinopharm For US$6.4 Million 32
China National Accord To Acquire 70% Stake In Guangdong Pharma Company For US$2.14 Million 33
China National Accord To Acquire Remaining 25% Stake In Suzhou Zhijun Wanqing Pharma From Yang Qiaoming For US$5 Million 34
Sinopharm Group Co Ltd - Key Competitors 35
Sinopharm Group Co Ltd - Key Employees 36
Sinopharm Group Co Ltd - Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Joint Venture 38
Recent Developments 39
Financial Announcements 39
Jul 31, 2017: Sinopharm Group: Proposed Re - Election And Appointment Of Directors And Supervisors 39
Mar 24, 2017: Sinopharm Group: Annual results announcement for the year ended 31 December 2016 40
Mar 20, 2017: Sinopharm Group: Announcement Preliminary Results of Sinopharm Accord for the Year Ended 31 December 2016 43
Corporate Communications 44
Mar 24, 2017: Sinopharm Group: Change in chairman of the board 44
Other Significant Developments 45
May 31, 2017: Sinopharm Launches New Logo 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List Of Tables

List of Tables
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sinopharm Group Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 9
Sinopharm Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sinopharm Plans to Acquire Pharmacy Business from Shanghai Fosun Pharma 13
Chi-Med Forms Joint Venture with Sinopharm 14
Mitsubishi Forms Joint Venture With Sinopharm 15
China NT Pharma To Form Joint Venture With Sinopharm 16
Aeterna Zentaris Enters into Licensing Agreement with Sinopharm A-Think for Zoptarelin Doxorubicin 17
Provectus to Enter into Licensing Agreement with Sinopharm-CSIPI and Sinopharm A-THINK for PV-10 18
Sinopharm Raised USD728 Million in Private Placement of Shares 20
Sinopharm Completes Private Placement Of Shares For US$525 Million 22
Sinopharm Group Plans Public Offering Of Bonds For US$633 Million 24
China National Accord Medicines Plans to Acquire Remaining 90% Stake in Zhuhai-Based Pharma Firm for USD1.43 Million 25
Shanghai Shyndec Pharma to Acquire Stakes in 12 Pharma Companies for USD1.2 Billion 26
Sinopharm Plans to Acquire Three Pharmacies from Shanghai Fosun Pharma for USD67 Million 27
Hutchison China MediTech And Sinopharm Acquires 51% Stake In Sinopharm Holding HuYong Pharma For USD9.6 Million 28
Mitsubishi And Medipal Each Acquire 20% Stake In Sinopharm Holding Beijing Tianxingpuxin Bio-Med 30
Sinopharm Group To Acquire 80% Stake In Sinopharm Group Shanxi For US$132.6 Million 31
Merro Pharma To Sell 42.5% Stake In Shanghai Merro Pharma To Sinopharm For US$6.4 Million 32
China National Accord To Acquire 70% Stake In Guangdong Pharma Company For US$2.14 Million 33
China National Accord To Acquire Remaining 25% Stake In Suzhou Zhijun Wanqing Pharma From Yang Qiaoming For US$5 Million 34
Sinopharm Group Co Ltd, Key Competitors 35
Sinopharm Group Co Ltd, Key Employees 36
Sinopharm Group Co Ltd, Subsidiaries 37
Sinopharm Group Co Ltd, Joint Venture 38

List Of Figures

List of Figures
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sinopharm Group Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sinopharm Group Co Ltd, Medical Devices Deals, 2012 to YTD 2018 10

Sinopharm Group Co Ltd (1099) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Sinopharm Group Co Ltd (Sinopharm), a subsidiary of China National Pharmaceutical Group Corp is a distributor of pharmaceutical and healthcare products. The group provides distribution, logistics and other value-added services

USD 250 View Report

Sinopharm Group Co Ltd Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Sinopharm Group Co Ltd Company Profile is a detailed strategic and analytical report on Sinopharm Group Co Ltd. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Dian Diagnostics Group Co Ltd (300244) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Dian Diagnostics Group Co Ltd (Dian Diagnostics) is a medical diagnostic service provider. The company provides forensic authentication services, commercialization of diagnostic products, research and development in medical diagnostics and

USD 250 View Report

Shandong Dongming Petrochemical Group Co Ltd - Oil & Gas - Deals and Alliances Profile

Shandong Dongming Petrochemical Group Co Ltd (Dongming Petrochemical) is a chemicals manufacturing company that offers chemicals and petrochemicals. The groups products include gasoline, diesel, LPG, solvent oil, liquid paraffin, polypropylene,

USD 250 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available